相关实验视频

Updated: May 11, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

MEIBO ( perfluorohexyloctane):是一种治疗干眼病的新方法

Ayesha Azhar¹, Muskan A Taimuri¹, Malik Olatunde Oduoye²

¹Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Annals of medicine and surgery (2012)

|September 6, 2024

概括

梅博 ( perfluorohexyloctane) 为干眼病 (DED) 提供了一种新的治疗方法,可将膜蒸发率降低高达80%. 这种干预可以保护眼睛表面,减轻DED患者因干燥应激造成的损伤.

科学领域:

眼科医生眼科眼科
眼睛表面疾病眼睛表面疾病
药理干预药理干预

背景情况:

干眼病 (DED),或皮质结膜炎 (KCS),是一种多因素的眼睛表面状况,通常是由膜超度引起的.
DED表现出各种症状,包括红色,灼热和视觉障碍,影响生活质量.
目前的DED治疗有局限性,需要新的治疗方法.

研究的目的:

审查干眼病的病因学和当前的治疗策略.
评估Meibo ( perfluorohexyloctane) 用于DED管理的临床疗效,安全性和试验数据.
为了突出梅博在保护眼睛表面的独特作用机制.

主要方法:

使用PubMed,Medline和谷歌学者数据库进行全面的文献搜索.
对专注于干眼病差异,病因和现有干眼病干预措施的研究进行分析.
综述临床试验数据, perfluorohexyloctane (PFHO) 的疗效和安全概况.

主要成果:

梅博 ( perfluorohexyloctane) 是一个FDA批准的干预措施,用于DED管理.
perfluorohexyloctane 眼滴可以将眼睛表面的盐水蒸发量降低高达 80%.
梅博在眼睛表面提供屏蔽作用,减少因干燥应激引起的损伤.

结论:

梅博 ( perfluorohexyloctane) 为干眼疾病提供了一个有前途的治疗选择.
它独特的配方和作用机制解决了DED病理生理学的关键方面.
进一步的临床评估支持 perfluorohexyloctane 在管理 DED.的作用.

关键词:

美国食品和药物管理局的食品和药物管理局.梅博 ( perfluorohexyloctane) 是一种多氧化.干眼疾病是干眼的疾病.皮质结膜炎 (Sicca) 是一种疾病.完全化基洛克坦 (perfluorohexyloctane) 是一种含的化合物.

更多相关视频

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...